Golmehr Sistani

Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

Mina Swiha, Duncan E. K. Sutherland, Golmehr Sistani et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 28 citations · Full text

The value of 99mTc-sestamibi single-photon emission computed tomography-computed tomography in the evaluation and risk stratification of renal masses

Golmehr Sistani, Jennifer Bjazevic, Zahra Kassam et al. · Canadian Urological Association Journal · 2020 · 21 citations · Full text

Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study

Golmehr Sistani, Duncan E. K. Sutherland, Amol Mujoomdar et al. · Current Oncology · 2020 · 21 citations · Full text

Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer

Bobby Shaygan, Katherine Zukotynski, François Bénard et al. · Canadian Urological Association Journal · 2021 · 20 citations · Full text

Oncologic Imaging, Pet-mri, Positron Emission Tomography +16

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada

Sympascho Young, Ur Metser, Golmehr Sistani et al. · Frontiers in Oncology · 2021 · 11 citations · Full text

Oncologic Imaging, Pet-mri, Cancer Registration +17